Ebola Virus RNA May Persist in Semen, Breast Milk for Longer Than Anticipated
Data from a large sample of Ebola survivors confirmed the persistence of Ebola viral RNA in semen for up to 6 months.
Emerging Diseases
Emerging Diseases
Featured Article
Latest News
Antibiotic and Antiviral Combination to Treat Influenza
Compared with patients prescribed only an antiviral, patients who are prescribed both an antiviral and antibiotic have a lower risk for 3-day respiratory hospitalization.
Harnessing Key Elements of the Ebola Virus in Animal Models of Glioblastoma
A glycoprotein in Ebola called the mucin-like domain may be of interest in the development of an oncolytic for brain cancer.
QOL Similar After Surgery, Antibiotics for Uncomplicated Appendicitis
For patients being treated for uncomplicated acute appendicitis, quality of life (QOL) is similar at seven years after appendectomy or antibiotic therapy.
Macrolide Use During Pregnancy Linked to Major Fetal Malformations
Prescribing macrolide antibiotics during the first trimester of pregnancy is associated with an increased risk for major fetal malformation.
Treatment Considerations for Pan-Drug-Resistant Gram-Negative Infections
When treating infections caused by gram-negative pan-drug-resistant bacteria, colistin and/or tigecycline-based combination empiric therapy is recommended.
One-Quarter of Antibiotic Prescriptions at Children’s Hospitals Suboptimal
One in three children are prescribed antibiotics at children’s hospitals, and 25.9% prescribed antibiotics for infectious use are receiving at least one suboptimal antibiotic
Chinese Report Says Majority of Coronavirus Cases Are Mild
New details on nearly 45,000 cases of COVID-19 in China show that 80 percent of cases are mild and the number of new cases has been declining for most of February.
UTI Recurrence in Pediatric Patients: Antibiotic Treatment Duration Examined
In pediatric patients, the duration of antibiotic treatment for uncomplicated UTI was not significantly associated with UTI recurrence.
Coagulation Disorders and Bleeding Risks With Cefoperazone-Sulbactam
Of patients who received cefoperazone-sulbactam, 9.2% reported a coagulation disorder and 15.7% reported a decrease in platelet count.
CDC Outlines US Process of Evaluating Patients for 2019-nCoV
Recognizing individuals at risk for 2019 novel coronavirus (2019-nCoV) infection is a key part of facilitating infection control and prevention and limiting transmission.
How Effective Is the WHO Recommended Antibiotic Regimen for Leprosy?
The multidrug antibiotic regimen for the treatment of paucibacillary and multibacillary leprosy seemed to show better clinical improvement of lesions compared with rifampin, ofloxacin, and minocycline and other treatment.
Antibiotics Are Unlikely Major Contributors to Childhood Obesity
Antibiotics do not appear to be associated with childhood obesity.
CT Scan Features Described for 2019 Novel Coronavirus Infection
Key CT findings have been characterized for patients infected with the 2019 novel coronavirus.
Several Antibiotics Linked to Hypoglycemia Despite Accounting for Glucose-Lowering Medications
Several antibiotics were found to be associated with hypoglycemia even after accounting for concomitant use of glucose-lowering medications.
Many Antibiotic Prescriptions Filled Without Infection-Related Diagnosis
More than one-quarter of antibiotic fills for Medicaid patients not associated with a clinician visit
More Americans Evacuated From China Due to Coronavirus
FDA announced Tuesday that it has fast-tracked a test for the virus to help speed screening efforts
Chinese Doctor Among First to Warn About Coronavirus Dies From Virus
Dr. Li Wenliang raised concerns about a cluster of illnesses that were similar to SARS
Rifampicin May Be Safer Than Isoniazid in Latent Tuberculosis Treatment
In patients without a contraindication, rifampicin may be the safest treatment option for latent tuberculosis (TB) infection.
FDA: Bacitracin for Injection to Be Withdrawn From Market
The FDA has requested that all manufacturers of bacitracin for injection voluntarily withdraw their product from the market.
Investigations of Pan-Resistant C auris Cases After Antifungal Treatment
The Centers for Disease Control and Prevention (CDC) summarized investigations into 3 cases of pan-resistant Candida auris infections in New York.
Want to read more?
Please login or register first to view this content.
Next post in Antibiotics, Antimicrobial Resistance
